Evidence map›Paper›PMID 42052919›Full record

ArticleBritish journal of haematology2026

Real-world comparison of peripheral neuropathy and treatment delivery between Pola-R-CHP and R-CHOP in DLBCL.

Nobuhiko Nakamura, Koichi Ohata, Tomohiro Aizaki, Yuto Kaneda, Yoshikazu Ikoma, Takuro Matsumoto, Hiroshi Nakamura, Serika Banno Matsuoka, Shiori Hishida Sadaka, Akio Suzuki and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in British journal of haematology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Nobuhiko NakamuraDepartment of Hematology and Infectious Disease, Gifu University Hospital, Gifu, Japan.ORCID https://orcid.org/0000-0003-1682-7777
Koichi OhataDepartment of Pharmacy, Gifu University Hospital, Gifu, Japan.
Tomohiro AizakiDepartment of Hematology and Infectious Disease, Gifu University Hospital, Gifu, Japan.
Yuto KanedaDepartment of Hematology and Infectious Disease, Gifu University Hospital, Gifu, Japan.ORCID https://orcid.org/0009-0005-5910-0609
Yoshikazu IkomaDepartment of Hematology and Infectious Disease, Gifu University Hospital, Gifu, Japan.ORCID https://orcid.org/0009-0008-4780-9137
Takuro MatsumotoDepartment of Hematology and Infectious Disease, Gifu University Hospital, Gifu, Japan.
Hiroshi NakamuraDepartment of Hematology and Infectious Disease, Gifu University Hospital, Gifu, Japan.
Serika Banno MatsuokaDepartment of Pharmacy, Gifu University Hospital, Gifu, Japan.
Shiori Hishida SadakaDepartment of Pharmacy, Gifu University Hospital, Gifu, Japan.
Akio SuzukiDepartment of Pharmacy, Gifu University Hospital, Gifu, Japan.ORCID https://orcid.org/0000-0003-2106-2123
Nobuhiro KanemuraDepartment of Hematology and Infectious Disease, Gifu University Hospital, Gifu, Japan.
Masahito ShimizuDepartment of Hematology and Infectious Disease, Gifu University Hospital, Gifu, Japan.ORCID https://orcid.org/0000-0002-1151-2058

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

diffuse large B‐cell lymphomaperipheral neuropathyPola‐R‐CHPpolatuzumab vedotinreal‐world studyrelative dose intensity

Identifiers

PMID42052919
PMCPMC13340509

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.